SCHEMBL13675356

SCHEMBL13675356

CCc1ccc(C(=O)N(C)CCN(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.50
▸ MCHR1 Q99705 1/20 0.48
▸ HDAC4 P56524 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ ESRRG P62508 1/20 0.47
▸ HPGD P15428 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ LIMK2 P53671 1/20 0.46
▸ PLK1 P53350 1/20 0.46
▸ PDK1 Q15118 1/20 0.44
▸ OPRD1 P41143 2/20 0.44
▸ DRD2 P14416 1/20 0.43
▸ MLYCD O95822 1/20 0.43
▸ ACACB O00763 1/20 0.42
▸ THRA P10827 2/20 0.42
▸ THRB P10828 2/20 0.42
▸ HDAC1 Q13547 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ PDE7A Q13946 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12309792 0.87 ACACB (0.52) ALDH1A1MCHR1MEN1KMT2AESRRG
SCHEMBL10076226 0.86 ALDH1A1 (0.50) ALDH1A1MCHR1HDAC4MEN1KMT2A
SCHEMBL24607683 0.84 ALDH1A1 (0.51) ALDH1A1MEN1KMT2AESRRGHPGD
SCHEMBL22537607 0.84 ALDH1A1 (0.48) ALDH1A1MCHR1MEN1KMT2AESRRG
SCHEMBL8429483 0.83 ALDH1A1 (0.55) ALDH1A1HDAC4MEN1KMT2AESRRG
SCHEMBL25975198 0.81 HDAC4 (0.49) MCHR1HDAC4ESRRGPDK1OPRD1
SCHEMBL12237841 0.81 CDK4 (0.50) ALDH1A1MCHR1HDAC4ESRRGSMN1; SMN2
SCHEMBL12334126 0.80 PARP1 (0.55) MEN1KMT2AHPGDSMN1; SMN2PDK1
SCHEMBL1409728 0.80 PHLPP2 (0.56) ALDH1A1MCHR1HDAC4ESRRGPDK1
SCHEMBL6034132 0.80 CDK4 (0.51) ALDH1A1MCHR1HDAC4ESRRGPDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090270381-A1 Non-steroidal progesterone receptor modulators BAYER SCHERING PHARMA AG (DE) 2009-10-29 — — US disclosed
WO-2009077186-A1 NONSTEROIDAL PROGESTERONE RECEPTOR MODULATORS BAYER SCHERING PHARMA AKTIENGESLLSCHAFT (DE) 2009-06-25 — — WO disclosed
US-20090075989-A1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS BAYER SCHERING PHARMA AG (DE) 2009-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270381-A1 Non-steroidal progesterone receptor modulators PGR, PGRMC1, PGRMC2 ALDH1A1 1257/4885MCHR1 408/4885HDAC4 1604/4885
US-20090075989-A1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS NR5A1, CYP19A1, GPER1 ALDH1A1 695/4885MCHR1 219/4885HDAC4 1956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback